Synthesis and antioxidant screening of new 2-cyano-3-(1,3-diphenyl-1H-pyrazol-4-yl)acryloyl amide derivatives and some pyrazole-based heterocycles

Sallam, H.A.; Elgubbi, AS; Eman A. E. El-Helw;

Abstract


The high functionality compound namely 2-cyano-3-(1,3-diphenyl-1H-pyrazol-4-yl)acryloyl chloride (1) was utilized as a building block synthon via reactions with some nitrogen and sulfur nucleophilic reagents. The present work was planned to study the effect of 2-cyano group on the reactivity and stability of C2–C3 double bond toward different strong-to-weak nucleophiles, in addition to its facility of nucleophilic addition at C2–C3 double bond to construct new heterocyclic derivatives. The proclivity toward some mono-, 1,2-, 1,3-, 1,4-, and 1,5-binucleophiles was investigated. The reaction with 2-cyanoacetohydrazide was mainly dependent on the reaction conditions. Some new heterocycles integrated with pyrazole scaffold were successfully synthesized, such as benzoxazinone, indoline, isoindoline, pyrazolone, chromene, and pyrimidopyrimidine derivatives. Some of the newly synthesized compounds were screened for their antioxidant activity using ABTS method, and the results revealed that some compounds exhibited promising inhibitory antioxidant activity.


Other data

Title Synthesis and antioxidant screening of new 2-cyano-3-(1,3-diphenyl-1H-pyrazol-4-yl)acryloyl amide derivatives and some pyrazole-based heterocycles
Authors Sallam, H.A. ; Elgubbi, AS; Eman A. E. El-Helw 
Keywords Antioxidant;benzoxazinone;iminochromene;pyrimidopyrimidine;pyrazole;ANTIMICROBIAL ACTIVITIES
Issue Date 2-Jul-2020
Publisher TAYLOR & FRANCIS INC
Journal Synthetic Communications 
Volume 50
Issue 13
Start page 2066
End page 2077
ISSN 0039-7911
DOI 10.1080/00397911.2020.1765258
Scopus ID 2-s2.0-85085349121
Web of science ID WOS:000535093300001

Recommend this item

Similar Items from Core Recommender Database

Google ScholarTM

Check

Citations 24 in scopus
views 25 in Shams Scholar


Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.